Hansa Raises $121m To Fund Idefirix Launch
Big Plans For Antibody-Cleaving Enzyme
Having recently signed a gene therapy collaboration with Sarepta and received a positive opinion from the CHMP for its kidney transplant therapy, Sweden's Hansa has now raised a substantial sum in a "multiple times oversubscribed" placing.
